121 related articles for article (PubMed ID: 31315756)
1. Integrative Analysis Confirmed the Association between Osteoprotegerin and Osteoporosis.
Tang H; Zhu XW; Wu LF; Mo XB; Deng FY; Lei SF
Chin Med Sci J; 2019 Jun; 34(2):147-156. PubMed ID: 31315756
[TBL] [Abstract][Full Text] [Related]
2. The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women: A meta-analysis.
Peng Y; Sheng X; Xue F; Qian Y
Medicine (Baltimore); 2018 Dec; 97(51):e13507. PubMed ID: 30572450
[TBL] [Abstract][Full Text] [Related]
3. The effect of A163G polymorphism in the osteoprotegerin gene on osteoporosis related traits in Slovak postmenopausal women.
Krajcovicova V; Omelka R; Durisová J; Martiniakova M; Galbavy D; Bauerova M
Anthropol Anz; 2015; 72(3):311-9. PubMed ID: 26131575
[TBL] [Abstract][Full Text] [Related]
4. Association of
Abdi S; Binbaz RA; Mohammed AK; Ansari MGA; Wani K; Amer OE; Alnaami AM; Aljohani N; Al-Daghri NM
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572979
[TBL] [Abstract][Full Text] [Related]
5. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA
Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083
[TBL] [Abstract][Full Text] [Related]
6. The role of CD40 and CD40L in bone mineral density and in osteoporosis risk: A genetic and functional study.
Panach L; Pineda B; Mifsut D; Tarín JJ; Cano A; García-Pérez MÁ
Bone; 2016 Feb; 83():94-103. PubMed ID: 26545336
[TBL] [Abstract][Full Text] [Related]
7. Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis.
Lee YH; Woo JH; Choi SJ; Ji JD; Song GG
Mol Biol Rep; 2010 Jan; 37(1):227-34. PubMed ID: 19642016
[TBL] [Abstract][Full Text] [Related]
8. The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density.
Mencej-Bedrac S; Prezelj J; Kocjan T; Teskac K; Ostanek B; Smelcer M; Marc J
J Mol Endocrinol; 2009 Mar; 42(3):239-47. PubMed ID: 19131500
[TBL] [Abstract][Full Text] [Related]
9. The influence of osteoprotegerin genetic polymorphisms on bone mineral density and osteoporosis in Chinese postmenopausal women.
Sun T; Chen M; Lin X; Yu R; Zhao Y; Wang J
Int Immunopharmacol; 2014 Sep; 22(1):200-3. PubMed ID: 24975835
[TBL] [Abstract][Full Text] [Related]
10. The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density.
Celczyńska Bajew L; Horst Sikorska W; Bychowiec B; Wykrętowicz A; Wesoły J; Michalak M
Kardiol Pol; 2011; 69(6):573-8. PubMed ID: 21678294
[TBL] [Abstract][Full Text] [Related]
11. The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women.
Zhao HY; Liu JM; Ning G; Zhao YJ; Zhang LZ; Sun LH; Xu MY; Uitterlinden AG; Chen JL
Osteoporos Int; 2005 Dec; 16(12):1519-24. PubMed ID: 15782282
[TBL] [Abstract][Full Text] [Related]
12. Bone Metabolism and the c.-223C > T Polymorphism in the 5'UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease.
Krela-Kaźmierczak I; Kaczmarek-Ryś M; Szymczak A; Michalak M; Skrzypczak-Zielińska M; Drwęska-Matelska N; Marcinkowska M; Eder P; Łykowska-Szuber L; Wysocka E; Linke K; Słomski R
Calcif Tissue Int; 2016 Dec; 99(6):616-624. PubMed ID: 27639566
[TBL] [Abstract][Full Text] [Related]
13. Association between osteoprotegerin gene polymorphism and bone mineral density in patients with adolescent idiopathic scoliosis.
Eun IS; Park WW; Suh KT; Kim JI; Lee JS
Eur Spine J; 2009 Dec; 18(12):1936-40. PubMed ID: 19705167
[TBL] [Abstract][Full Text] [Related]
14. RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus.
Bonfá AC; Seguro LP; Caparbo V; Bonfá E; Pereira RM
Osteoporos Int; 2015 May; 26(5):1563-71. PubMed ID: 25609157
[TBL] [Abstract][Full Text] [Related]
15. The relationship between osteoprotegerin gene polymorphisms and bone mineral density in Chinese postmenopausal women.
Wang Q; Chen Z; Huang Y; Li Q; Zhu L; Cai X; He G; Xie Y; Liu Q
Int Immunopharmacol; 2013 Oct; 17(2):404-7. PubMed ID: 23856613
[TBL] [Abstract][Full Text] [Related]
16. Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women.
Feng G; Meng L; Wang H; Lu Y; Jia J; Zhang Y; Zhang H; Zhang B
J Pediatr Endocrinol Metab; 2012; 25(11-12):1141-4. PubMed ID: 23329761
[TBL] [Abstract][Full Text] [Related]
17. Association between osteoprotegerin genetic variants and bone mineral density in Chinese women.
Shen L; Qiu Y; Xing S; Chen D; Zhu Y; He X; Wang J; Lai J; Shi G; Liao T; Tan J
Int Immunopharmacol; 2013 Jun; 16(2):275-8. PubMed ID: 23619553
[TBL] [Abstract][Full Text] [Related]
18. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
19. Common Variants in OPG Confer Risk to Bone Mineral Density Variation and Osteoporosis Fractures.
Sheng X; Cai G; Gong X; Yao Z; Zhu Y
Sci Rep; 2017 May; 7(1):1739. PubMed ID: 28496203
[TBL] [Abstract][Full Text] [Related]
20. Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women.
Zupan J; Mencej-Bedrac S; Jurković-Mlakar S; Prezelj J; Marc J
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):102-6. PubMed ID: 19896533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
